Traditional Chinese medicine composition for treating cardiovascular and cerebrovascular diseases

A technology of cardiovascular and cerebrovascular diseases and compositions, applied in the field of medicine, can solve problems such as decreased elasticity of arterial vessel walls, unsatisfactory curative effect, difficulty in thrombolysis, etc., and achieve good therapeutic effect

Inactive Publication Date: 2016-02-24
姜辉阳
View PDF2 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In the prevention and treatment of cardiovascular and cerebrovascular diseases, although interventional therapy, surgery, statins, anti-platelet agents and thrombolytic agents of modern medicine have been applied clinically, the curative effect is not ideal, and it only achieves the temporary effect of dilating blood vessels and improving circulation. It has little effect on the melting of exfoliated plaque or thrombus flowing in blood vessels, and it is difficult to dissolve thrombosis; and frequent use of such western medicines will easily lead to a decrease in the elasticity of the arterial vessel wall and an increase in fragility, resulting in cerebral infarction gradually turning into cerebral infarction. Severe bleeding occurs again, resulting in a larger infarction, which is difficult to cure, and a small number of patients will have adverse reactions after using it. The side effects are relatively large, and the clinical cure rate is not ideal.
Therefore, the current drugs for the treatment of cardiovascular diseases are still insufficient

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0013] Weigh 12 grams of curculigo, 12 grams of Panax notoginseng, 10 grams of breviscapus, 18 grams of Polygonum multiflorum, 20 grams of Pueraria lobata, 30 grams of rhubarb, 20 grams of mulberry, 8 grams of green bark, 5 grams of coptis, 20 grams of safflower, and 15 grams of rehmannia , 10 grams of fairy spleen, 20 grams of ginseng, 20 grams of dandelion, 15 grams of epimedium, 12 grams of Chuanxiong, 20 grams of capillary, 20 grams of angelica, 15 grams of Achyranthes bidentata, 12 grams of asparagus, 50 grams of astragalus, and Liushenqu 10 grams, 10 grams of schisandra, 10 grams of salvia, 15 grams of tangerine peel, 12 grams of huixincao, 15 grams of Morinda officinalis, 20 grams of sealwort, 25 grams of dodder, 12 grams of calamus and 12 grams of melon shell, crushed, over 100 Mesh sieve, mix evenly to obtain powder.

experiment example

[0015] Select 180 clean-grade SD rats, weighing 180-220g, half male and half female. After adaptively feeding the rats for 7 days, blood was taken from the tail vein to detect the blood lipid level to exclude the influence of unhealthy experimental animals on the experimental results. , sex Rats were randomly divided into 6 groups and reared in separate cages, which were respectively normal group, model group, positive drug group, drug administration group 1, drug administration group 2 and drug administration group 3, 30 in each group. Except for the normal group fed with common feed, the rats in other groups were first given vitamin D 3 700,000 IU / kg, intragastric administration within 3 days (the normal group was given the same volume of normal saline), and then fed with high-fat feed (weight %): cholesterol 1%, propylthiouracil 0.61%, sodium taurocholate 0.35% , 5% lard, 93.04% basal feed, and fed for 8 weeks to create an animal model of dyslipidemia.

[0016] Dosing was ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a traditional Chinese medicine composition for treating cardiovascular and cerebrovascular diseases. The composition is prepared from rhizoma curculiginis, pseudo-ginseng, erigeron breviscapus, polygonum multiflorum, radix puerariae, rheum officinale, loranthus parasiticus, pericarpium citri reticulatae viride, coptis chinensis, flos carthami , radix rehmanniae preparata, herba epimedii, ginseng, dandelion, herba epimedii, ligusticum wallichii, oriental wormwood, angelica sinensis, radix achyranthis bidentatae, asparagus fern, astragalus membranaceus, medicated leaven, schisandra chinensis, salvia miltiorrhiza, pericarpium citri reticulatae, red rhodobryum, morinda officinalis, rhizoma polygonati, semen cuscutae, rhizoma acori graminei and snake gourd fruit shells. The traditional Chinese medicine composition has an extremely good treatment effect on cardiovascular and cerebrovascular diseases, and is ideal medicine for treating cardiovascular and cerebrovascular diseases at present.

Description

technical field [0001] The invention relates to the field of medicine, in particular to a traditional Chinese medicine composition for treating cardiovascular and cerebrovascular diseases. Background technique [0002] Cardiovascular and cerebrovascular diseases have become the most important diseases that threaten human health and life. According to the data released by the Ministry of Health of China in 2005, cardiovascular and cerebrovascular diseases are the diseases with the highest morbidity and mortality in our country. There are as many as 160 million patients every year, and about 2.6 million people die of cardiovascular and cerebrovascular diseases every year. And the onset population tends to be younger (35-55 years old). In the prevention and treatment of cardiovascular and cerebrovascular diseases, although interventional therapy, surgery, statins, anti-platelet agents and thrombolytic agents of modern medicine have been applied clinically, the curative effect ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/8969A61P9/00A61P3/06A61K31/454
Inventor 姜辉阳
Owner 姜辉阳
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products